LYFIX Mutual Fund

LYFIX Mutual Fund (AlphaCentric Life Sciences and Healthcare Fund Class I) is managed by Alpha Centric Fund with $38.0M in net assets. LYFIX expense ratio is 1.41%, holding 62 positions across sectors including Health Care, Financials. Inception date: 2019-11-29.

LYFIX performance shows a YTD return of 13.73%. The 1-year return is 34.29% and the 5-year return is 9.48%. LYFIX dividend yield stands at 1.58%, paid annually.

LYFIX top holdings include Gilead Sciences (5.5%), Nvaesrtex Pharmaceuticals Inc (5.3%), Astrazeneca Plc (4.6%), First Am Treas Obli-X (4.3%), Roivant Sciences Ltd. Common Shares (3.7%). Go to all LYFIX holdings, LYFIX sectors, or LYFIX dividends.

LYFIX can be compared against other funds. Use LYFIX overlap to find shared positions, or LYFIX vs another fund for a side-by-side view. LYFIX alternatives are available via the screener, along with tax-loss harvesting opportunities.